Table 1 Liver function and serum amylase levels after the ligation of the common bile duct in rats (93)

Size: px
Start display at page:

Download "Table 1 Liver function and serum amylase levels after the ligation of the common bile duct in rats (93)"

Transcription

1

2 Table 1 Liver function and serum amylase levels after the ligation of the common bile duct in rats (93)

3 Fig. 1 Serum insulin (IRI) and plasma glucagon (IRG) levels after the ligation of the common bile duct. Fig. 3 Electron micrograph of the acinar cells at 2nd weeks after ligation. ( ~5,000). A lot of zymogen granules (Z) were preserved and intracellular organells were well developed. N: Nucleus, G: Golgi Apparatus, Mt: Mitochondria, rer: rough Endoplasmic Reticulum, Lu: Acinar lumen Fig. 2 Light micrograph of the pancreas at 2nd weeks after ligation (H-E Staining, ~200) (94)

4 Fig. 6 Light micrograph of pancreas at the 4th Fig. 4 Electron micrograph of B cells at 2nd weeks after ligation. ( ~10,000). Many of B cells preserved a lot of secretory granules and their intracellular organelles were well developed. Sg: Secretory granule, rer: rough Endoplasmic Reticulum, G: Golgi apparatus, Mt: Mitochon dria weeks after ligation, (H-E Staining, ~100) Fig. 5 Electron micrograph of B cells at 2nd weeks after ligation. ( ~30,000) Granular mem branesfused with each other and (ƒ -shaped exocytosis ( ª) were often observed. Ca: Capil larylumen, Sg: Secretory granule (95)

5 Fig. 7 Electron micrograph of acinar cells at the 4th weeks after ligation. Acinar lumen ( ª) became narrow and the acinar parenchyma became atrophic with marked decrease of zymogen granules.( ~5,000). N: Nucleus, rer: rough Endoplasmic Reticlum Fig. 9 Electron micrograph of A cells at the 4th weeks after ligation. Many of A cells showed enlargement of the Golgi apparatus and juvenile secretory granules were observed around them. ( ~8,000) N: Nucleus, G: Golgi apparatus, rer: rough Endoplasmic Reticulum. Fig. 8 Electron micrograph of B cells at the 4th weeks after ligation. Many of B cells showed degenerative changes: decrease in their secretory granules, swollen cisternae of the rough endoplas micreticulum and appearance of vacuoles. ( ~ Fig. 10 Electron micrograph of A cells at the 4th weeks after ligation. ( ~25,000). ƒ -shaped exocytosis ( ª) were often observed at the capil larylumen. Sg: Secretory granuled, Ca: Capillar ylumen 10,000). V: Vacuole, Ly: Lysosome, Mt: Mito chondria,sg: Secretory granule (96)

6 Table 2 Diameter and number of zymogen granules in acinar cells. (mean }SD) (* p<0.05) (97)

7

8 3) Opie EL: Cholelithiasis and pancreatic disease. Amer J Med Sci 121: 27, ) Kelly TR: Gallstone pancreatitis: Patho physiology.surgery 80: 488, ) Thurston OG: Pathogenesis of gallstone pan creatitis.amer J Surg 120: 301, ) ŽO î Ž, ¼: _ Î Ç ÆäX Š. ŠO ÈŽ Ã, 3: 355, ) Luft JH: Improvements in epoxy resin embed dingmethods. J Biophys Biochem Cytol 9: 409, ) Tuzhilin SA, et al: Hepatic lesions in pan creatitisclinicoexperimental data. Amer J Gastroent 64: 108, ) Zieve L, et al:: Secretion of pancreatic enzyme. III. Response of patients with cirrhosis to se cretinand pancreozymin. Am J Dig Dis 12: 303, ) Ermak TH, et al: Zymogen granules of pan creasdecrease in size in response to feeding. Cell Tissue Res 214: 51, ) Starzl YE, et al: The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet 140: 549, ) Bucher NLR, et al: Regulation of hepatic regeneration in rats by synergetic action of insulin and glucagon. Proc Nat Acad Sci 72: 1157, ) c Œd, ¼: äx à ª å ŠŠÖ- B [-ƒ Ž ŽhŒƒ Ž Ì Ý ð ß Á Ä. ˆãŠw Ì ä Ý, 99: 179, ) Marco J: Elevated plasma glucagon level in cirrhosis of the liver. N Engl J Med 289: 1107, ) Scherwin RS: Hyperglucagonemia in cirrhoss: Altered secretion and sensitivity to glucagon. Gastroenterology 74: 1224, ) Muller WA, et al: The influence of the antece dentdiet upon glucagon and insulin secretion. New Eng J Med 285: 1450, ) Felig P, et al: Concentration of glucagon and

9 ELECTRON MICROSCOPIC OBSERVATION ON THE PANCREAS AFTER THE EXPERIMENTAL LIGATION OF THE COMMON BILE DUCT IN RATS Keiho SHIM, Ichikun KO, Euichol KIM, Katsusuke SATAKE and Kaoru UMEYAMA 1st Department of Surgery, Osaka City University Medical School The present examination has been attempted to investigate morphological changes of pancreatic acinar and islet cells after complete ligation of common bile duct in rats using electron microscope. At the early stage of the ligation of the common bile duct (2nd weeks after the ligation), the most of acinar cells and B cells of the Langerhans islands showed hyperfunctional appearance, but no remarkable changes were observed in the A cells. At the late stage (4th weeks after the ligation), acinar cells became atrophied and B cells were degenerative changes, however many of A cells showed hyperfunctional appearance. (100)

Ÿ ( ) ,166,466 18,586,390 85,580,076 88,457,360 (31) 1,750,000 83,830,000 5,000,000 78,830, ,388,808 24,568, ,480 6,507,1

Ÿ ( ) ,166,466 18,586,390 85,580,076 88,457,360 (31) 1,750,000 83,830,000 5,000,000 78,830, ,388,808 24,568, ,480 6,507,1 ( ) 60,000 120,000 1,800,000 120,000 100,000 60,000 60,000 120,000 10,000,000 120,000 120,000 120,000 120,000 1,500,000 171,209,703 5,000,000 1,000,000 200,000 10,000,000 5,000,000 4,000,000 5,000,000

More information

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This

More information

untitled

untitled Ÿ Ÿ ( œ ) 120,000 60,000 120,000 120,000 80,000 72,000 100,000 180,000 60,000 100,000 60,000 120,000 100,000 240,000 120,000 240,000 1,150,000 100,000 120,000 72,000 300,000 72,000 100,000 100,000 60,000

More information

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Laboratory Medicine University School of Medicine, Tohoku

More information

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Oral Physiology, Hokkaido University School of Dentistry,

More information

untitled

untitled ( œ ) œ 138,800 17 171,000 60,000 16,000 252,500 405,400 24,000 22 95,800 24 46,000 16,000 16,000 273,000 19,000 10,300 57,800 1,118,408,500 1,118,299,000 109,500 102,821,836 75,895,167 244,622 3,725,214

More information

( ) 1,771,139 54, , ,185, , , , ,000, , , , , ,000 1,000, , , ,000

( ) 1,771,139 54, , ,185, , , , ,000, , , , , ,000 1,000, , , ,000 ( ) 6,364 6,364 8,884,908 6,602,454 218,680 461,163 1,602,611 2,726,746 685,048 2,022,867 642,140 1,380,727 18,831 290,000 240,000 50 20. 3.31 11,975,755 1,215,755 10,760,000 11,258,918 (68) 160,000 500,000

More information

( š ) š 13,448 1,243,000 1,249,050 1,243,000 1,243,000 1,249,050 1,249, , , ,885

( š ) š 13,448 1,243,000 1,249,050 1,243,000 1,243,000 1,249,050 1,249, , , ,885 ( š ) 7,000,000 191 191 6,697,131 5,845,828 653,450 197,853 4,787,707 577,127 4,000,000 146,580 146,580 64,000 100,000 500,000 120,000 60,000 60,000 60,000 60,000 60,000 200,000 150,000 60,000 60,000 100,000

More information

Ÿ ( ) Ÿ ,195,027 9,195,027 9,195, ,000 25, ,000 30,000 9,000,000 9,000, ,789, ,000 2,039,145 3,850,511 2,405,371

Ÿ ( ) Ÿ ,195,027 9,195,027 9,195, ,000 25, ,000 30,000 9,000,000 9,000, ,789, ,000 2,039,145 3,850,511 2,405,371 Ÿ ( ) Ÿ 540,000 980,000 300,000 700,000 1,200,000 1,100,000 1,300,000 980,000 400,000 220,000 280,000 400,000 300,000 220,000 1,300,000 460,000 260,000 400,000 400,000 340,000 600,000 1,500,000 740,000

More information

untitled

untitled š ( ) 300,000 180,000 100,000 120,000 60,000 120,000 240,000 120,000 170,000 240,000 100,000 99,000 120,000 72,000 100,000 450,000 72,000 60,000 100,000 100,000 60,000 60,000 100,000 200,000 60,000 124,000

More information

untitled

untitled 24 591324 25 0101 0002 0101 0005 0101 0009 0101 0012 0101 0013 0101 0015 0101 0029 0101 0031 0101 0036 0101 0040 0101 0041 0101 0053 0101 0055 0101 0061 0101 0062 0101 0004 0101 0006 0101 0008 0101 0012

More information

( š ) œ 525, , , , ,000 85, , ,810 70,294 4,542,050 18,804,052 () 178,710 1,385, , ,792 72,547 80,366

( š ) œ 525, , , , ,000 85, , ,810 70,294 4,542,050 18,804,052 () 178,710 1,385, , ,792 72,547 80,366 ( š ) 557,319,095 2,606,960 31,296,746,858 7,615,089,278 2,093,641,212 6,544,698,759 936,080 3,164,967,811 20. 3.28 178,639,037 48,288,439 170,045,571 123,059,601 46,985,970 55,580,709 56,883,178 19. 4.20

More information

Ÿ ( Ÿ ) Ÿ šœš 100,000 10,000,000 10,000,000 3,250,000 1,000,000 24,350,000 5,000,000 2,500,000 1,200,000 1,000,000 2,960,000 7,000,000 1,500,000 2,200

Ÿ ( Ÿ ) Ÿ šœš 100,000 10,000,000 10,000,000 3,250,000 1,000,000 24,350,000 5,000,000 2,500,000 1,200,000 1,000,000 2,960,000 7,000,000 1,500,000 2,200 šœ Ÿ ( Ÿ ) Ÿ 3,658,819,708 612,940,933 1,441,054,976 1,536,693,282 369,033,491 1,167,659,791 68,105,057 25,460 7,803,540,263 1,713,934,550 541,531,413 702,848,302 11,827 1,552,629,488 23,421,737,374 2,572,144,704

More information

untitled

untitled š š ( œ ) 170,000,000 23. 2.14 9,925,843 525,843 9,400,000 9,896,851 9,000,000 9,000,000 400,000 400,000 7,809,518 2,850,232 2,285,616 2,673,670 2,087,333 36,000 1,273,004 373,800 211,050 162,750 40,529

More information

untitled

untitled ( œ ) œ 2,000,000 20. 4. 1 25. 3.27 44,886,350 39,933,174 4,953,176 9,393,543 4,953,012 153,012 4,800,000 164 164 4,001,324 2,899,583 254,074 847,667 5,392,219 584,884 7,335 4,800,000 153,012 4,800,000

More information

š ( š ) ,148,770 3,147,082 1, ,260 1,688 1,688 10,850 10, , ,

š ( š ) ,148,770 3,147,082 1, ,260 1,688 1,688 10,850 10, , , š ( š ) 60,000 240,000 120,000 60,000 120,000 360,000 72,000 1,128,000 56,380,000 14. 2.20 35,492,337 17,401,486 18,090,851 32,141,906 11,070,000 3,570,000 7,500,000 7,020,000 7,020,000 851 851 9,778,644

More information

untitled

untitled Ÿ ( œ ) ( ) lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll J ¾ 25 26. 3.28 19,834,572,598 5,567,519,745 14,267,052,853 13,701,344,859 (453,473) 1,293,339,800 306,707,318 306,707,318 9,096,921,367

More information

untitled

untitled š ( œ ) (Ÿ ) lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll J ¾ 21 22. 3.30 22,647,811,214 9,135,289,695 13,512,521,519 14,858,210,604 (438,585) 1,278,866,000 208,685,290 485,290 8,000,000

More information

Ÿ Ÿ ( ) Ÿ , , , , , , ,000 39,120 31,050 30,000 1,050 52,649, ,932,131 16,182,115 94,75

Ÿ Ÿ ( ) Ÿ , , , , , , ,000 39,120 31,050 30,000 1,050 52,649, ,932,131 16,182,115 94,75 Ÿ ( ) Ÿ 100,000 200,000 60,000 60,000 600,000 100,000 120,000 60,000 120,000 60,000 120,000 120,000 120,000 120,000 120,000 1,200,000 240,000 60,000 60,000 240,000 60,000 120,000 60,000 300,000 120,000

More information

( ) 2,335,305 5,273,357 2,428, , , , , , , ,758,734 12,834,856 15,923,878 14,404,867 3,427,064 1,287

( ) 2,335,305 5,273,357 2,428, , , , , , , ,758,734 12,834,856 15,923,878 14,404,867 3,427,064 1,287 ( ) 500,000 500,000 320,000 300,000 1,000,000 1,140,000 1,500,000 560,000 640,000 400,000 240,000 600,000 400,000 780,000 300,000 300,000 1,500,000 260,000 420,000 400,000 400,000 300,000 840,000 1,500,000

More information

Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin

Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamine butylbromide during upper gastrointestinal endoscopy.

More information

( ) œ ,475, ,037 4,230,000 4,224,310 4,230,000 4,230,000 3,362,580 2,300, , , , , , ,730 64,250 74

( ) œ ,475, ,037 4,230,000 4,224,310 4,230,000 4,230,000 3,362,580 2,300, , , , , , ,730 64,250 74 Ÿ ( ) œ 1,000,000 120,000 1,000,000 1,000,000 120,000 108,000 60,000 120,000 120,000 60,000 240,000 120,000 390,000 1,000,000 56,380,000 15. 2.13 36,350,605 3,350,431 33,000,174 20,847,460 6,910,000 2,910,000

More information

untitled

untitled š ( ) 200,000 100,000 180,000 60,000 100,000 60,000 120,000 100,000 240,000 120,000 120,000 240,000 100,000 120,000 72,000 300,000 72,000 100,000 100,000 60,000 120,000 60,000 100,000 100,000 60,000 200,000

More information

( ) g 900,000 2,000,000 5,000,000 2,200,000 1,000,000 1,500, ,000 2,500,000 1,000, , , , , , ,000 2,000,000

( ) g 900,000 2,000,000 5,000,000 2,200,000 1,000,000 1,500, ,000 2,500,000 1,000, , , , , , ,000 2,000,000 ( ) 73 10,905,238 3,853,235 295,309 1,415,972 5,340,722 2,390,603 890,603 1,500,000 1,000,000 300,000 1,500,000 49 19. 3. 1 17,172,842 3,917,488 13,255,354 10,760,078 (550) 555,000 600,000 600,000 12,100,000

More information

日本消化器外科学会雑誌第24巻第12号

日本消化器外科学会雑誌第24巻第12号 Malignant liver diseases hedatocellular carcinoma cholangiocellular carcinoma rnetastatic liver turnor Combined liver diseases liver cinhosis active hedalilis Ope.time (min) FiS. I Changes of lymphocyte

More information

untitled

untitled 23 59 13 23 24 0101 0001 0101 0002 0101 0001 0101 0002 0101 0007 0101 0009 0101 0012 0101 0026 0101 0031 0101 0033 0101 0056 0101 0059 0101 0075 0101 0076 0101 5001 0101 0002 0101 0003 0101 0008 0101 0010

More information

( ) 3,000,000 1,437, ,003,853 9,003,853 9,003,853 9,000,000 9,000,000 3,853 3,853 8,021,583 4,000, ,302 3,670, ,270

( ) 3,000,000 1,437, ,003,853 9,003,853 9,003,853 9,000,000 9,000,000 3,853 3,853 8,021,583 4,000, ,302 3,670, ,270 ( ) 800,000 300,000 460,000 1,440,000 500,000 1,500,000 1,200,000 400,000 21 900,000 21 1,500,000 820,000 720,000 760,000 400,000 300,000 600,000 1,000,000 440,000 600,000 1,500,000 1,000,000 400,000 980,000

More information

( ) œ 100, ,000 4,830,000 49,500,000 10,000,000 20,000,000 (1) 11,759, ,538, ,729 11,240,000 11,034

( ) œ 100, ,000 4,830,000 49,500,000 10,000,000 20,000,000 (1) 11,759, ,538, ,729 11,240,000 11,034 Ÿ ( ) œ 0 0 15. 3.18 70,877,493 629,493 70,248,000 70,128,000 70,248,000 550,000 31,698,000 38,000,000 200,000 200,000 69,928,000 68,800,000 1,128,000 500,000 50,000 j 70,000 j 160,000 j 380,000 100,000

More information

1) Dalton, A. J. et al. : J. Nat. Cancer Inst., 11 : 439, 1950. 2) Fawcett, D. W.: J. Nat. Cancer Inst., 15 :1475, 1955. 3) Oberling, C. et Rouiller, C.: Ann. d'anat. path., 1: 401, 1956. 4) Palade, G.

More information

š ( š ) ,400, , ,893, ,743, ,893, ,893, ,658,475 35,884,803 2,167,037 7,189,060 55,417,575 81,08

š ( š ) ,400, , ,893, ,743, ,893, ,893, ,658,475 35,884,803 2,167,037 7,189,060 55,417,575 81,08 Ÿ š ( š ) 1,970,400 5,000,000 12. 3.26 180,553,493 9. 9.29 41,772,995 10. 9.28 50,075,163 13. 2. 2 1,000,000 10.12.27 j 19,373,160 13. 4. 1 j 1,200,000 38. 3.19 j 1,100,000 6. 9.22 14. 1. 8 0 0 14. 3.13

More information

日本消化器外科学会雑誌第31巻第7号

日本消化器外科学会雑誌第31巻第7号 Key words: obstructive jaundice, biliary drainage, bile refeeding, hepatectomy Fig. 1 Animal models a: experiment I b: experiment 2 silicon tube Fig. 2 Experimantal design Sham Ope J - l r bile duct Zweeks

More information

官報(号外第196号)

官報(号外第196号) ( ) ( ) š J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 12 13. 3.30 23,850,358,060 7,943,090,274 15,907,267,786 17,481,184,592 (354,006) 1,120,988,000 4,350,000 100,000 930,000 3,320,000

More information

š ( š ) 7,930,123,759 7,783,750, ,887, ,887 3,800,369 2,504,646,039 i 200,000,000 1,697,600, ,316.63fl 306,200,

š ( š ) 7,930,123,759 7,783,750, ,887, ,887 3,800,369 2,504,646,039 i 200,000,000 1,697,600, ,316.63fl 306,200, š ( š ) (Ÿ ) J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 907,440,279 16 17. 3.30 23,805,381,307 7,603,591,483 16,201,789,824 15,716,666,214 (400,000) 1,205,390,461 200,000,000 200,000,000

More information

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urology, Kumamoto University College of Medicine (Director:

More information

untitled

untitled œ ( œ ) œ 847,120 2,343,446 2,343,446 45,242 25. 5.17 6,472,966 6,472,966 6,472,966 972,332 972,332 5,500,000 5,500,000 634 634 2,053,480 1,423,820 27,053 79,255 523,352 4,419,486 95,352 4,300,204 4,300,204

More information

š ( š ) (6) 11,310, (3) 34,146, (2) 3,284, (1) 1,583, (1) 6,924, (1) 1,549, (3) 15,2

š ( š ) (6) 11,310, (3) 34,146, (2) 3,284, (1) 1,583, (1) 6,924, (1) 1,549, (3) 15,2 š ( š ) ( ) J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 13 14. 3.29 23,586,164,307 6,369,173,468 17,216,990,839 17,557,554,780 (352,062) 1,095,615,450 11,297,761,775 8,547,169,269

More information

<82CD82B582B28C4E20666F E646F7773>

<82CD82B582B28C4E20666F E646F7773> CA20Ⅱ/23Ⅱ 電気回路図 «««««««š«««« M コード機能一覧表 1 ž ž ž ž «ªªª h ««««««««««ªªªªªªªªª «««««ªªªªªªªªª «««««ªªªªª ªª «««««z«e u «««««~ z«e u ««««««e u «««««««««ªªªªªz «««««ªªªªª «««««««««ªªª ªª ««««««e u «««««~

More information

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin

More information

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly

More information

untitled

untitled š ( œ ) 4,000,000 52. 9.30 j 19,373,160 13. 4. 1 j 1,400,000 15. 9.24 i 2,000,000 20. 4. 1 22. 5.31 18,914,932 6,667,668 12,247,264 13,835,519 565,000 565,000 11,677,790 11,449,790 228,000 4,474 4,474

More information

Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho

Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical School While the problem of late pregnant hypertension

More information

untitled

untitled š š ( œ ) 80,000 120,000 100,000 120,000 120,000 80,000 100,000 180,000 60,000 100,000 60,000 120,000 100,000 240,000 120,000 290,000 240,000 100,000 120,000 72,000 300,000 72,000 100,000 100,000 60,000

More information

<4D F736F F D2088CF88F589EF8E9197BF F690EC816A2E646F63>

<4D F736F F D2088CF88F589EF8E9197BF F690EC816A2E646F63> v w y ÆÎf ()1 1 1. Êu (1) Êu (2) Êu (3) vêu (4) ÆÎfÊu (5) ÉÊwŠ (6) Êd (7) Êu (8) ÇÍÌÉsÉÉÊ 2. Êu (1) Ê (2) Êd (3) Ê (4) Ê (5) Ê (6) Ê (7) ~ÉÊ (8) Ê ÈÉÍÌ (9) y 3. Ê~Êu}Ì 4. ÐÑÒdÊ 5. 6. ÈÊ ()1 2 1. Êu Êu

More information

1) Richter, C. P.: Ann. Rev. Physiol., 4, 561 (1942) 2) A. L. Fox: Proc. Nat. Acad. Sci., Wash., 18, 115(1931) 4) Hansen, R. u. W. Langer: Klin. Wschr, 9) Katsch, G. u. H. Pickert: Handb. d. Inn. Med.

More information

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, School of Medicine, Tokushima University, Tokushima Fetal

More information

<4D F736F F D2092B28DB882C982C282A282C42E646F63>

<4D F736F F D2092B28DB882C982C282A282C42E646F63> Íû Ñ ÐÑw x ÌÆÇÇ ÇÊÊ ÉÈÉÃÑ ÐÑwà v Ê ÉÇÂdvÊwÎxÇiÊ vèéìêéèâ Ñ ÐÑwÊËÊÊÎwÈÂÈËÉÊÊÆÇ ÍËÊfuÊ~ÎËÊÍÇÊÈÍÇÉÂvw ÊÉÌÊyÎÍÇÉÎÉÈÉÆÌÈ ÇÊwÊÂÇÊÎÿÉfÊÈÍvwÉÈÉ vwêêêuvwîuèâéêvèíéwéâéê ÎyÉÈ ÍÂÇÉÿÊvwÉÈ ÎÂsÌÊÂÆÍÆÊgyÉÈÉÇÈÉÆÉÉÇÍÊ

More information

Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date URL

Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date URL Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date 1958-01 URL http://hdl.handle.net/2433/111559 Right Type Departmental Bulletin

More information

1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing

More information

1) Roth, J., Glick, S. M., Yalow, R. S. and Berson, S. A.: Hypoglycemia: A potent stimulus to secretion of growth hormone. Science, 140, 987-988, 1963. 2) Ogawa, N.: Routine Ultramicro-Measurement of Human

More information

ÊÈÌÊ fêôöôï Ö É É ~ Œ ~ Œ ÈÍÉÆÍ s Ê É Â Ê ÉÉÆÍÇÉ Ê Ê É Ê ÈÍv ÈÍ É ÈÍ Â ÇÍ vèé Ê Ê É ÈÉËÈÆ ÊÌÉ Ê~Æ Ê Ê ÈÍfÆ Ê ÊÉÆÉÊ Ê Ê ÈÍ Ê ÈÉËÈÆ

ÊÈÌÊ fêôöôï Ö É É ~ Œ ~ Œ ÈÍÉÆÍ s Ê É Â Ê ÉÉÆÍÇÉ Ê Ê É Ê ÈÍv ÈÍ É ÈÍ Â ÇÍ vèé Ê Ê É ÈÉËÈÆ ÊÌÉ Ê~Æ Ê Ê ÈÍfÆ Ê ÊÉÆÉÊ Ê Ê ÈÍ Ê ÈÉËÈÆ Ê È Ì Ê 12 ~ (4 Â9 )ÊÍÍ ÿj fd 5.837 Ê Â Ð ÓÑ (TCSA) Ê fç 2.924 É Ê ÎzÆÉÆÌÈ Âÿj Ê sê 9  sê 5 Î ÉyÉÉÆÍÉÆÍÍÉÆÌÈ 13 Ê TCSA ÉsÊÉÉ w ÊÍÍÉ 53 Ê ƒ Êd ÊÂ11.700 ÉÊÉÉÆÌÈ ÆÌÌ s ÊÉÉÉ ÇÈÇÉÊÉÇÊÆ Ê ÉÈÇ ÉÆÆg É ÈÊÌÊÊÉÆÉÊÿj

More information

Ÿ ( ) Ÿ 7,488,161,218 7,396,414,506 91,708,605 38,107 4,376,047 2,037,557,517 1,000,000 i 200,000,000 1,697,600, ,316.63fl 306,200,000 14

Ÿ ( ) Ÿ 7,488,161,218 7,396,414,506 91,708,605 38,107 4,376,047 2,037,557,517 1,000,000 i 200,000,000 1,697,600, ,316.63fl 306,200,000 14 Ÿ ( ) (Ÿ ) Ÿ J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 17 18. 3.30 24,222,550,856 8,088,715,093 16,133,835,763 14,673,176,237 (400,000) 1,265,253,000 201,000,000 1,000,000 200,000,000

More information

( ) œ œ 50, , , , ,000 f 240, ,000 f21 30,000 1,000, ,725,367 18,680,993 9,044,374 11,219,342 9,000,000 9,

( ) œ œ 50, , , , ,000 f 240, ,000 f21 30,000 1,000, ,725,367 18,680,993 9,044,374 11,219,342 9,000,000 9, ( ) œ 58,287,360 13. 4.25 15. 3.14 513,273,280 131,411,617 381,861,663 329,679,509 7,100,000 1,500,000 5,600,000 374,761,663 374,742,000 19,663 18,006,875 12,382,661 114,390 804,787 4,705,037 311,672,634

More information

< F31332D8B638E FDA8DD E F1292E6A>

< F31332D8B638E FDA8DD E F1292E6A> v u x u ~ ÔÒÖ Ê f     u    Âl  d    ~{  d  y y x y v u f Ë s y v u y v u u Ë~ u y Ê v ÊÉÆÉ y v Ë v y ÿus y Ê Ê~ ÊÉÆÉ y v ~{ fy v Ê ÈÍ u ~ Ê v u ~ ÊÆÍÌÍÃÈÊ vyãê Í v u ~ Ê v u ~ ÊÆÍÌÍÃÈÊ vyãê

More information

XXXXXX XXXXXXXXXXXXXXXX

XXXXXX XXXXXXXXXXXXXXXX Å E D Ë@ÌÊè½ÌÄ\ { î{ t½ î. î G } b } b ÏäÝßØo 9 "Ä ¾ iž ¾ ¼ÀÀ Ð ÏäÝßØo 9 "Ä ¾ iž ¾ ¼ÀÀ Ð z z Þ Þ ÏäÝßØo : " ¾ ~C iž ò 0@ÀÀ Ð ÏäÝßØo : " ¾ ~C iž ò 0@ÀÀ Ð ÏäÝßØo ; " v ¼ÀÀ Ð ÏäÝßØo ; " v ¼ÀÀ Ð z z z z Þ

More information

首都圏チェーンストアチラシ出稿状況調査 リニューアル 2014 年 6 Sample 月版版

首都圏チェーンストアチラシ出稿状況調査 リニューアル 2014 年 6 Sample 月版版 首都圏チェーンストアチラシ出稿状況調査 リニューアル 2014 年 6 Sample 月版版 w ÛÝÝÜÛÚ ÜÛw àýüýà ÝÝ ÝÝÝÝÝÝÜÜÛÛÙÛÚÚÚ ÉÉÖ±Ö Öw ÖÛÝ݃ Ö ÝÝÝ ÖÜwÝÝÝ ÉÉÉÉ ÝÝ ÜÝ ÜÝÝ ÖÝÝÝÝÝÝÝÜÜ Ö Ö ÌÌ ààà Ê syµeêéêéê ÊÉÊÊÊ Ê e ÉÊÉÊÊÉÊ ÊÉÊÊÊ Ê ÝÜÝÝ ÊÉÊÊ ÊÊÉÊÊÊ

More information

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc 4 54 55 56 ( ( 1994 1st stage 2nd stage 2012 57 / 58 365 46.6 120 365 40.4 120 13.0 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 4 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97

More information

東京都健康安全研究センター研究年報

東京都健康安全研究センター研究年報 Ann. Rep. Tokyo Metr. Inst. P.H., 54, 347352, 2003 A Low Dose Effects of Bisphenol A on the Ultrastructure of Prostate in Suckling Male Rats Nobutaka FUKUMORI, Kuniaki TAYAMA, Hiroshi ANDO, Yoshikazu KUBO,

More information

日本消化器外科学会雑誌第29巻第9号

日本消化器外科学会雑誌第29巻第9号 Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

More information

CHEMOTHERAPY

CHEMOTHERAPY CHEMOTHERAPY Fig.1 Effect of 6059-S on body weight changes in male rats Table 1 Effect of 6059-S on body weight changes in female rats :Mean }S.E. Table 2 Reproductive findings of rats treated with 6059

More information

Microsoft Word - 484号.doc

Microsoft Word - 484号.doc ~s~é~díê ÈÍ~ ~vêíí w gé Ê~Ê Âf Âyf ÉÊÍÂ Ê ËÍÊÉÊÇÈËÉÎÍÉÆÆÃÒÖÔÖÃ ÉÆÉÉÉuÆ ÍÆÂÈÉÇÉiwÊ}ÈËÇÇÉÉÊÆÍÂÈÇÈÊÇÍÂ~ ÊÇÎu ÍÉ Êf ÇÍ Ê ÉÍÈÇÊÇuÍÍÍÌÊ ÊÂyfÊ ÇÍ ÉÊÆÍÂfi ÉÆÆ ÊÊÈÍÉÆÍÂ ËÍÊÒÖÔÖÉÆÆÎ ÍÉÎÉ ÉÉÆÆÉÇÊÎÉÊÇÍÌÆÍÍÊÆÉÆÍÆÂ

More information

š š o š» p š î å ³å š š n š š š» š» š ½Ò š ˆ l ˆ š p î å ³å š î å» ³ ì š š î å š o š š ½ ñ š å š š n n å š» š m ³ n š

š š o š» p š î å ³å š š n š š š» š» š ½Ò š ˆ l ˆ š p î å ³å š î å» ³ ì š š î å š o š š ½ ñ š å š š n n å š» š m ³ n š š š o š» p š î å ³å š š n š š š» š» š ½Ò š ˆ l ˆ š p î å ³å š î å» ³ ì š š î å š o š š ½ ñ š å š š n n å š» š m ³ n š n š p š š Ž p í š p š š» n É» š å p š n n š û o å Ì å š ˆ š š ú š p š m å ìå ½ m î

More information

988 CHEMOTHERAPY NOV. 1971

988 CHEMOTHERAPY NOV. 1971 988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical

More information

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration

More information

VOL. 36 S-3 CHEMOTHERAPY 437

VOL. 36 S-3 CHEMOTHERAPY 437 VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,

More information

1272 CHEMOTHERAPY MAR. 1975

1272 CHEMOTHERAPY MAR. 1975 1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides

More information

VOL.39 S-3

VOL.39 S-3 VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose

More information

fm

fm ÁÓ ÒÏÏÎ u ªª ª ª ª ª ª ª ª ª ª ªªª h ª ªª ª ªª ªªª ªª ª h ªª ª ª ª ªªªª ª ª ª ªª ªª ªª ª ªª ªª ª ª ª ª ª ª ª ª ª w d ª ªªª ª ª ª «ª ª««sˆ t ª ª«««~ s~ ª ªª ª ª ª ª ªªªªªªªª s s~ ªªªªª ªª ªªª ª ª ªª ª ª

More information

fm

fm ÁÔÖÐÖÕ Ð +1 f ª ª ª ª ««««ªªª f ª ªª ª ªª ª ªª ª f ªªª ªª ª ªªª f ªª ª f f ªª ª ª ª ~ &'(556#46 &'(5#761 &'(5/#0 &'(5/#0 &'(5%;%.' &'(5/+)+ &'(5*+&#4+ &'(12+0 &'(1*#0&&90 &'(1*#0&/#' &'(12+072 &'(1#+4

More information

„¤‰ƒ‰IŠv‚æ‡S−ª†{“Å‘IB5-97

„¤‰ƒ‰IŠv‚æ‡S−ª†{“Å‘IB5-97 Ê f Î~ÈÉ ÇÊ Êg Ê ÉÇÍÎ Ê g w } o k ÊÈÌÊ Ê ÉÇÍ v É {ÊÈÍ ÊfÆÎ ÇÈÉÇ f h ËÊzÇÇÍ ŒÎ ÍÊÆ xê f Ê fëê Ê ÈÍ Ê ÔÖ ÒÉ Ê ÆÉ Æ ÊƒÆ f vè ÆÊw Ê Ê ÍÍ Æ f ÆÍÍÊ ÊÈÌÊ ÉÊ ÇÍ ÌÉÃvÌÉ ÊÈ ÃÎÒ ÔÊ Çs ÍÍÉÆÍ ÇsÍÍÉÆÉÂ Ì É Ê ÎsÉÉÂ

More information

< F31332D817992B48DC A8CCB8E9F81458CA28E942E6A7464>

< F31332D817992B48DC A8CCB8E9F81458CA28E942E6A7464> 一般国道 10 号 戸次犬飼拡幅 ŠÊu ÊËu ÎÍÊ Êy y Ê~ Ê~Êu}Ì ÐÑÒdÌÊh ŠÊu ÿj~ Êu ÿj~ Ê ÎzÉÈ ÎÈÉ ÊiÍ Êud~{ÉÆ ÍÂÊ uêiîí ÉuÊ{dÉÆÍ ËÉÇÆÊÇÆ ÇÊÆÉŠÊ xgdésèéæ ÎzÉÉÆÍÂzÎÓÏÓÑ ÎŠÓÏÓÑ ÉÈÂÉÎËuÊ ÉÆÍ v Ê Ó ÐÎÊ~Ê ÊÍÍÇm ÈÇÂÌÉÂ~ÌÊ~ÇÈÍÍÊÊÂ

More information

Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery

Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery, Osaka Kosei-Nenkin Hospital K. Izawa and S. Wakitani

More information

34号 目 次

34号 目 次 1932 35 1939 π 36 37 1937 12 28 1998 2002 1937 20 ª 1937 2004 1937 12 º 1937 38 11 Ω 1937 1943 1941 39 æ 1936 1936 1936 10 1938 25 35 40 2004 4800 40 ø 41 1936 17 1935 1936 1938 1937 15 2003 28 42 1857

More information

ロシア人の名前

ロシア人の名前 10 12 15 18:35 19:15 19:30 19:40 19:50 ðàñêîëîòü îäèîí îìàíû àñêîëüíèêîâ P äàí åæäàí Šðàñ åêðàñ àéäþí îëüøîé ðåòüßê Œîðîç îëê ûê Šîò îðîáåé 862 988 (3/15) (3/15) (3/16) (3/17) (3/18) (3/19 3/22) 18 25

More information

CHEMOTHERAPY APR. 1984

CHEMOTHERAPY APR. 1984 VOL.32 S-3 CHEMOTHERAPY dihydro-4-oxo-7-(1-piperazinyl)-1, 8-naphthyridine- CHEMOTHERAPY APR. 1984 VOL.32 S-3 CHEMOTHERAPY Table 1 Implantation rates and post- implantation survival rates in females mated

More information

Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa

Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Department of Obstetrics and Gynecology, Kobe University

More information

„¤‰ƒ‰IŠv‚æ‡S−ª†{“Å‘IB5-97

„¤‰ƒ‰IŠv‚æ‡S−ª†{“Å‘IB5-97 vè ÆÎ~ÈÉfÆÍÇÉÊÉÇÍ Êg Ê Ê ÇÉ g w y ÊÈÌÊ {v É Ê Š vè ÆËÊ vè ÆÊ ÍÊvÌ vè ÆÎ ÈÈÍvÌ É Ê ÍÍ * Î~ÉÉ * Ê ÈÍ ÊŠÆ ÃÍÇÍÊÆÃÊ f ÆÍÍÊ ÊÈÌÊ ÌÉÊ ÊÂÊÆÈÉÌxf ÊÉÉÉÊ ÊÊÍÇÉÉÆÉÉÂÇÍÉÃf ÆÍ ÃÇ ÊÉÇÊÉÍÆÇÂÒÑÒÉ Î ÍÈÍÇÉÍÍÌÂ É Éh Î ÊÉ

More information

( œ ) œ ,906,148,000 1,800,000,000 1,706,469,380 1,350,676, ,793,167 1,555,793,167 3,000,000, ,537, ,

( œ ) œ ,906,148,000 1,800,000,000 1,706,469,380 1,350,676, ,793,167 1,555,793,167 3,000,000, ,537, , ¾ œ ( œ ) (Ÿ ) lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll J N I Q ( œ ) œ 14 15. 3.28 2,906,148,000 1,800,000,000 1,706,469,380 1,350,676,213 355,793,167 1,555,793,167 3,000,000,000

More information

CHEMOTHERAPY AUG. 1982 VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection

More information

<4D F736F F D2088CF88F589EF8E9197BF81698CA28E9490E78DCE816A2D312E646F63>

<4D F736F F D2088CF88F589EF8E9197BF81698CA28E9490E78DCE816A2D312E646F63> ÿj~ ~{ 犬飼千歳道路 Š~{Êu ÊËu ÎÍÊ Êy Ê~ Ê~Êu}Ì ÐÑÒdÌÊh Š~{Êu ~{Êu ~{ÊÊv{dÊÈÍÉu~{ÉÂ ÎzÉÈÉÎÈÊiÍ MO Êi ~{ÉÆ ÍÂ ~{ÊÂÂÎÉÈÉÈÍÈÍÊÎÊ~ÈÂ ÊÎ~ÈÍÉÉÌÊÂdÊÂÊÈÍÇÉÎ ÉÈÉ~{ÉÆÍÂ ÌÉÂdyi ~Ëi ~É~ÈÍÍÇÉÊÍÍÂÓ ÒÒÖ ÐÇÈÍÂÈÌÈÌÊÉÊÇhÉÊÍÂ Ÿe

More information

胆石症

胆石症 ,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic

More information

ƒsnsªf$o;ª ±Ž vf$o; Uûâ éf$o;ê &fgxo2nvô¾c"gõ /R=o^Ô¾C"GÕ ±Ž v Ô)"GÕâésâf$o; évâöá:o2øüîãá ãòá ùô f$ o;ê u%,âô G Ô Õ HÎ ÔµnZÕ Ñì ÔD[n Õ bg(fååøô Õ½ Š3

ƒsnsªf$o;ª ±Ž vf$o; Uûâ éf$o;ê &fgxo2nvô¾cgõ /R=o^Ô¾CGÕ ±Ž v Ô)GÕâésâf$o; évâöá:o2øüîãá ãòá ùô f$ o;ê u%,âô G Ô Õ HÎ ÔµnZÕ Ñì ÔD[n Õ bg(fååøô Õ½ Š3 1 Excel ( 1) Web (http://163.136.122.41/enquete/enquete.htm) 9 AHP x5 http://www.senshu-u.ac.jp/~thc0456/text/ 1995 1995 1995 S C 1995 2 1 4 1, 2 1, 2 1. 2. 3. 4. 1. 2. 3. 4. 5. ( XY 6. 6 9 AHP 4 AHP 0.15

More information

<4D F736F F D2088CF88F589EF8E9197BF816991E596EC927C A2E646F63>

<4D F736F F D2088CF88F589EF8E9197BF816991E596EC927C A2E646F63> ÿj~ ~{ 大野竹田道路 ~{Êu ÊËu ÎÍÊ Êy Ê~ Ê~Êu}Ì ÐÑÒdÌÊh ~{Êu ~{Êu ~{ÊÂÊv{dÊÈÍÉu~{ÉÂ ÎzÉÈÉÎÈÊiÍ MO Êi ~{É ÆÍÂ ~{ÊÂÂÎÉÈÉÈÍÈÍÊÎÊ~ÈÂ ÊÎ~ÈÍÉÉÌÊÂdÊÂÊÈÍÇÉÎ ÉÈÉ~{ÉÆÍÂ ÌÉÂdyi ~Ëi ~É~ÈÍÍÇÉÊÍÍÂÓ ÒÒÖ ÐÇÈÍÂÈÌÈÌÊÉÊÇhÉÊÍÂ ~{

More information

Microsoft Word - ’V‘é−gŁš.doc

Microsoft Word - ’V‘é−gŁš.doc ÿj~ Êu ÊËu ÎÍÊ Êy Ê~ Ê~Êu}Ì ÐÑÒdÌÊh ~{ 2 1 Êu ÿj~ Êu ~Êÿj~ ÊÂÇÍÊiÍ MO Ê{dÉÆÍ ÂÊÊ ÊuÊÎdyÉÆÍ {dêâi ~ +%ÌuËÊÎÐÑÑ~{ÉÆÍ ÉÎˈÊuÊ{dÉÆÍÂÌÉÂ~~ÍÊdÊÊÌ ÂvÇ ÉÆÍÇÉÇÍ ÊÊ~{ÉÉÌ ÎÆ{dÉÊÉÉÆÍ Êu u ÿj~ ÊÊ~ÊÊÂÇ~ÉÆÍÂy ÊÊ

More information

Ò ÑÔÏÓ ÐÎ ÆÉ z uññòõ w g ÌÊÉÇÍ ˆ ˆ Ð Ö Ò z Ò ÑÔÏÓ Ð ÓÑÐÒÒ ÎÔÖÏÖ ÎÖÐÖÑÕ uôöðöõ Î~ËÍÂÌÉÂ ÑÑÒÕÊ ÉÊÍ ÌÆÇÇ Î Ê ÈÂÊÈÇÊÓÑÐÒÒ ÇÂ z uêèéæíçî ÍÇÊÈÍÂ t Ê Ç ÈÍÂ Â

Ò ÑÔÏÓ ÐÎ ÆÉ z uññòõ w g ÌÊÉÇÍ ˆ ˆ Ð Ö Ò z Ò ÑÔÏÓ Ð ÓÑÐÒÒ ÎÔÖÏÖ ÎÖÐÖÑÕ uôöðöõ Î~ËÍÂÌÉ ÑÑÒÕÊ ÉÊÍ ÌÆÇÇ Î Ê ÈÂÊÈÇÊÓÑÐÒÒ Ç z uêèéæíçî ÍÇÊÈÍ t Ê Ç ÈÍ  w g ÌÊÉÇÍ ˆ ˆ Ð Ö Ò z Ò ÑÔÏÓ Ð ÓÑÐÒÒ ÎÔÖÏÖ ÎÖÐÖÑÕ uôöðöõ Î~ËÍÂÌÉÂÑÑÒÕÊÉÊÍ ÌÆÇÇ ÎÊÈÂÊÈÇÊÓÑÐÒÒ ÇÂzuÊÈÉÆÍÇÎÍÇÊ têç ÂÊ Çt~Ê ~ÈÍÒ ÑÔ ÑÊnÈÍ Â Â z zê}âšzê ÍÍÆÊÊÉÉÂÇÍÊÆÂÎÈΠʈÉÇÉÊÇÂÎÔÑ Ð ÓÑyʈÇÍÌ xèíëçjîèízuññòõë

More information

Table 1 Characteristics of the study participants in Imari municipal hospital

Table 1 Characteristics of the study participants in Imari municipal hospital Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin

More information

CHEMOTHERAPY 52 MAY d a a. Normal S. aureus d Đg/ml, 2h; e b b Đg/ml, Abnormal e. division lh; Abnormal thickening division cross f c. 1

CHEMOTHERAPY 52 MAY d a a. Normal S. aureus d Đg/ml, 2h; e b b Đg/ml, Abnormal e. division lh; Abnormal thickening division cross f c. 1 Levloxacin V.:1 Z iiiir fa L CHEMOTHERAPY 52 MAY d a a. Normal S. aureus d. 0.39 Đg/ml, 2h; e b b. 0.10 Đg/ml, Abnormal e. division lh; Abnormal thickening division cross f c. 1992 0.39 Đg/ml, and Fig.

More information

9) Reichen J, Paumgartner G: Relationship be- tween bile flow and Na+, K+-Adenosinetriphos- phatase in liver plasma membranes enriched in bile canaliculi. J Clin Invest 60: 429-434, 1977 10) Schaffner

More information

Microsoft Word - −C−…−gŁš.doc

Microsoft Word - −C−…−gŁš.doc ÿj~ Êu ÊËu ÎÍÊ Êy Ê~ Ê~Êu}Ì ÐÑÒdÌÊh ~{ 3 1 Êu ÿj~ Êu ~Êÿj~ ÊÂÇÍÊiÍ MO Ê{dÉÆÍ ÂÊÊ ÊuÊÎdyÉÆÍ {dêâi ~ +%ÌuËÊÎÐÑÑ~{ÉÆÍ ÉÎˈÊuÊ{dÉÆÍÂÌÉÂ~~ÍÊdÊÊÌ ÂvÇ ÉÆÍÇÉÇÍ ÊÊ~{ÉÉÌ ÎÆ{dÉÊÉÉÆÍ Êu u ÿj~ ÊÊ~ÊÊÂÇ~ÉÆÍÂdÊÊÇ

More information

慢性膵炎

慢性膵炎 - - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider

More information

Ear Res Jpn Morphological Sutudy of the Effect of acute Hypertension and Hypotension on the Permeability of Blood Vessels of vestibular Organs

Ear Res Jpn Morphological Sutudy of the Effect of acute Hypertension and Hypotension on the Permeability of Blood Vessels of vestibular Organs Ear Res Jpn 16 105 Morphological Sutudy of the Effect of acute Hypertension and Hypotension on the Permeability of Blood Vessels of vestibular Organs M.Sakagami*, M.Sano**, T.Harada**, T.Matsunaga**, T.Kubo*

More information

EVALUATION OF NOCTURNAL PENILE TUMESCENCE (NPT) IN THE DIFFERENTIAL DIAGNOSIS OF IMPOTENCE Masaharu Aoki, Yoshiaki Kumamoto, Kazutomi Mohri and Kazunori Ohno Department of Urology, Sapporo Medical College

More information

Takio ICHITANI and Teruko HIGASHIKAWA: Germination of Aphanomyces iridis oospores on the basal medium for selective isolation with addition of bacteri

Takio ICHITANI and Teruko HIGASHIKAWA: Germination of Aphanomyces iridis oospores on the basal medium for selective isolation with addition of bacteri Takio ICHITANI and Teruko HIGASHIKAWA: Germination of Aphanomyces iridis oospores on the basal medium for selective isolation with addition of bactericides and fungicides Summary This study examined the

More information

<4D F736F F D BB388E78CA48B B E6338AAA2B92B290AE2B E646F63>

<4D F736F F D BB388E78CA48B B E6338AAA2B92B290AE2B E646F63> ÈÆÉÇÍÊ ÈÍÿf ÃËÆÃÎ~ÈÉ g w ÊÈÌÊ ÊÈÌÊ Êv ÈÆÉÇÍ vƒ ÇÍË ÊvÈÆ ÊÊÇÆvÈ uêæí ÉÊÃÌÉÌà {ÎÆ ÆÍÍÊ ÌÉÊÂiÍÊÊÈÉÃÊÉÉÉÊÉÊÇÃÉÆÉÉÆÇÇÎÈÉ ÇÆÉÉÉÍÆÇÂÉÈÉÂÇÍÌÉ ÊÎ~ÇÈÉÊÇÉÌÊÊÂÊ ÌixʈÊÊ ÊÊÊÇÉÉÂ}ÊÎÈÉÍÂÊÎÆÇËÉ ÍÈÊÇÍÍÎÉvÊÆÍÇÂÎÇÈÉÌÊÎfÆÍÇÉÊÊÇÉÉÊÉÆÍÂ

More information

Table 1 Antibacterial spectra of CPM and other antimicrobials against anaerobes Fig. 1 In vitro activity of CPM and other antibiotics against B. fragilis (136 strains) Fig. 2 In vitro activity of CPM and

More information

日本消化器外科学会雑誌第30巻第3号

日本消化器外科学会雑誌第30巻第3号 Key words : gastric cancer, progltostic factor. multivariate analysis Factors selected after Coffelation- after Stepwise rnitrally check check H o s t l A g e C O 2 S e x C O 3 Pre-op. compliation O Treatment

More information

<4D F736F F D208B7B8DE890BC5F90E096BE8E9197BF5F2D F4390B32E646F63>

<4D F736F F D208B7B8DE890BC5F90E096BE8E9197BF5F2D F4390B32E646F63> 一般国道 10 号 宮崎西バイパス ÿj~ uóïóñêu ÊËu ÎÌÇÍÊ Ê eêu Êv wêæí ÊvÊu vêu uvêèív ~{ 1 ÿj~uóïóñêu ÿj~êu ÿj~êâîzéè Î ÈÂ ÊiÍ MOÊud~{ÉÆÍÂÊÎ dèí{dêâêuëuî~èíuê{ déæíâêââîèíîééæíâ ÿj~uóïóñêu u uóïóñêâuê~êuîíâ~ê ÉÎÈÍÇÉÎÊsÉÉÌÊÉÆÍÂ

More information

VOL. 34 S-2 CHEMOTH8RAPY 913

VOL. 34 S-2 CHEMOTH8RAPY 913 VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(

More information

Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks

Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks Fig. 1 Chemical structure DL-8280 Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks Fig. 3 Food consumption in rats treated orally with DL-8280 for 4 weeks Fig. 4 Water consumption

More information

840 Geographical Review of Japan 73A-12 835-854 2000 The Mechanism of Household Reproduction in the Fishing Community on Oro Island Masakazu YAMAUCHI (Graduate Student, Tokyo University) This

More information